GlassScriptPhysician profile
Lenore G Chen
NPI 1235421447
$1,381.37
in general payments reported to CMS, 2019-2025
12 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $270 · 2022: $278 · 2023: $121 · 2024: $393 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $876.17 | 2021-2025 | Lybalvi, Aristada |
| Teva Pharmaceuticals USA, INC. | $145.02 | 2023-2024 | Uzedy |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $107.17 | 2025 | Rejoyn |
| Sunovion Pharmaceuticals INC. | $40.08 | 2021 | |
| Janssen Pharmaceuticals, INC | $38.93 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $33.27 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $32.54 | 2025 | Cobenfy |
| Abbvie INC. | $29.68 | 2021-2024 | |
| Brainsway USA INC | $25.60 | 2024 | Brainsway Deep Tms System |
| Jazz Pharmaceuticals INC. | $19.24 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.12 | 2021 | |
| Indivior INC. | $16.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lenore Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.